Brought to you by 
SciFluor licenses Harvard’s fluorine chemistry technology
22 Mar 2012
Executive Summary
Coinciding with its $5mm seed financing, SciFluor Life Sciences LLC has announced an exclusive worldwide license from Harvard University to fluorination methodologies--to improve the properties of pharmaceuticals--in addition to a pipeline of fluorinated compounds.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
-
Diagnostic Imaging Equipment & Supplies
-
Biotechnology
- Drug Discovery Tools
- Synthesis Technologies, Production Processes
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SciFluor licenses Harvard’s fluorine chemistry technology
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice